Skip to content
Prof Tom John· @TommyJohn00 · X·· 1 day agoScore45

#LCSM

Body · original

@LeXiuning giving excellent discussion on ctDNA dynamics. Notable that those without ctDNA at baseline derive limited benefit from addition of chemo. But questions about whether persistence warrants addition of chemo versus treating all ctDNA+ #LCSM #ESMO26

7 views · 0 likes · 0 reposts · 0 replies

Source: Prof Tom John · x.com

CBACBA Frontier Insights (CFI)Chinese Biopharmaceutical Association (CBA)www.cba-usa.org